- ByInvesting.com-
Investing.com -- Deceuninck NV (BR:DECB) announced a significant leadership change as the company’s Board of Directors has decided...
Last | High | Low | |||||
---|---|---|---|---|---|---|---|
228.80 | 228.80 | 224.80 | +3.40 | +1.51% | 20.26K | ||
76.90 | 77.70 | 76.30 | +0.15 | +0.20% | 65.53K | ||
103.45 | 103.55 | 102.55 | +0.80 | +0.78% | 302.02K | ||
28.28 | 28.58 | 28.14 | +0.18 | +0.64% | 170.35K | ||
75.45 | 75.50 | 75.10 | +0.55 | +0.73% | 54.16K | ||
194.30 | 194.60 | 189.50 | +4.00 | +2.10% | 121.42K | ||
52.10 | 52.36 | 51.58 | -0.46 | -0.88% | 1.23M | ||
62.15 | 62.70 | 61.90 | +0.45 | +0.73% | 246.86K | ||
14.00 | 14.11 | 13.83 | +0.10 | +0.72% | 328.7K | ||
65.00 | 66.00 | 64.80 | -0.60 | -0.91% | 73.37K | ||
97.00 | 97.55 | 95.90 | 0.00 | 0.00% | 74.98K | ||
8,330.0 | 8,410.0 | 8,320.0 | +60.0 | +0.73% | 556 | ||
67.45 | 68.25 | 67.20 | +0.05 | +0.07% | 21.47K | ||
67.10 | 67.30 | 66.40 | +0.20 | +0.30% | 30.11K | ||
281.20 | 281.60 | 277.00 | +3.80 | +1.37% | 18.23K | ||
21.56 | 21.62 | 21.34 | +0.16 | +0.75% | 321.44K | ||
185.70 | 186.80 | 184.70 | +0.30 | +0.16% | 27.17K | ||
556.60 | 560.40 | 552.40 | +5.80 | +1.05% | 57.01K | ||
13.06 | 13.17 | 13.01 | -0.04 | -0.31% | 222.22K | ||
76.74 | 77.70 | 76.04 | +0.68 | +0.89% | 124.48K |
Investing.com -- Deceuninck NV (BR:DECB) announced a significant leadership change as the company’s Board of Directors has decided...
Investing.com -- Bank of America’s Beat Factor Top 10 list for August is heavily weighted toward financial stocks, with five...
Investing.com -- Nyxoah SA (BR:NYXH) (NASDAQ:NYXH) stock jumped 9.4% following FDA approval of its Genio system for treating...
Upcoming U.S. retail sales data is expected to influence market perceptions, building on a recent increase. Companies like Target...
After the Iran-Israel situation fizzled out for the time being, the Cboe Volatility Index (VIX) dropped from its yearly high of...
Dividend stocks can provide regular income and outperform the broader market. When building a dividend portfolio, investors should...
No Earning Reports have been scheduled